According to BioLineRx's latest financial reports the company's current EPS (TTM) is -$1.25. In 2022 the company made an earnings per share (EPS) of -$0.62 an increase over its 2021 EPS that were of -$0.83.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.21 | 94.86% |
2022 | -$0.62 | -25% |
2021 | -$0.83 | -66.67% |
2020 | -$2.49 | -29.41% |
2019 | -$3.53 | -19.05% |
2018 | -$4.36 | -22.22% |
2017 | -$5.60 | -3.57% |
2016 | -$5.81 | -0% |
2015 | -$5.81 | -17.65% |
2014 | -$7.06 | -55.26% |
2013 | -$15.77 | -36.9% |
2012 | -$25.00 | 11.81% |
2011 | -$22.36 | -737.01% |
2010 | $3.51 |